SCHEMBL17204262

SCHEMBL17204262

CCOC(=O)C=C(N)Cc1cccc(OC)c1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CTBP2 P56545 1/20 0.48
ALDH1A1 P00352 3/20 0.46
MAPK8 P45983 1/20 0.46
KDM4E B2RXH2 1/20 0.46
MAPT P10636 1/20 0.46
IDO1 P14902 1/20 0.43
AGXT P21549 1/20 0.43
PARP1 P09874 1/20 0.43
TAAR1 Q96RJ0 1/20 0.43
CYP1A2 P05177 1/20 0.43
RAB9A P51151 1/20 0.43
SIGMAR1 Q99720 1/20 0.43
POLB P06746 1/20 0.43
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MTNR1A P48039 1/20 0.42
MTNR1B P49286 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17204261 1.00 CTBP2 (0.48) CTBP2ALDH1A1MAPK8KDM4EMAPT
SCHEMBL30172840 1.00 CTBP2 (0.48) CTBP2ALDH1A1MAPK8KDM4EMAPT
SCHEMBL30768637 0.85 CTBP2 (0.49) CTBP2ALDH1A1KDM4EMAPTCYP1A2
SCHEMBL4317748 0.83 CTBP2 (0.56) CTBP2ALDH1A1MAPK8IDO1AGXT
SCHEMBL4317744 0.83 CTBP2 (0.56) CTBP2ALDH1A1MAPK8IDO1AGXT
SCHEMBL3179495 0.83 CTBP2 (0.47) CTBP2ALDH1A1KDM4EMAPTTAAR1
SCHEMBL8949906 0.82 MAPT (0.47) ALDH1A1MAPTTSHRMAPK1L3MBTL1
SCHEMBL8949899 0.82 MAPT (0.47) ALDH1A1MAPTTSHRMAPK1L3MBTL1
SCHEMBL511950 0.79 POLB (0.56) CTBP2ALDH1A1KDM4EMAPTCYP1A2
SCHEMBL29640755 0.79 POLB (0.56) CTBP2ALDH1A1KDM4EMAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111620870-B Compound and application thereof in expansion of hematopoietic stem cells and/or hematopoietic progenitor cells 蒙特利尔大学 2023-01-03 CN disclosed
CN-111620870-A Compound and application thereof in expansion of hematopoietic stem cells and/or hematopoietic progenitor cells 蒙特利尔大学 2020-09-04 CN disclosed
CN-106414445-B Compound and application thereof in expansion of hematopoietic stem cells and/or hematopoietic progenitor cells 蒙特利尔大学 2020-07-03 CN disclosed
US-10647718-B2 Compounds and use thereof in the expansion of hematopoietic stem cells and/or hematopoietic progenitor cells Universitéde Montréal (CA) 2020-05-12 US disclosed
EP-3134409-B1 COMPOUNDS AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS AND/OR HEMATOPOIETIC PROGENITOR CELLS UNIV MONTREAL (CA) 2020-02-12 EP disclosed
EP-3134409-A1 COMPOUNDS AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS AND/OR HEMATOPOIETIC PROGENITOR CELLS Université de Montréal (CA) 2017-03-01 EP disclosed
US-20170037047-A1 COMPOUNDS AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS AND/OR HEMATOPOIETIC PROGENITOR CELLS UNIVERSITE DE MONTREAL (CA) 2017-02-09 US disclosed
WO-2015161373-A1 COMPOUNDS AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS AND/OR HEMATOPOIETIC PROGENITOR CELLS Université de Montréal (CA) 2015-10-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10647718-B2 Compounds and use thereof in the expansion of hematopoietic stem cells and/or hematopoietic progenitor cells HPGDS, HCLS1, THPO CTBP2 3440/4885ALDH1A1 19/4885MAPK8 2731/4885
US-20170037047-A1 COMPOUNDS AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS AND/OR HEMATOPOIETIC PROGENITOR CELLS HPGDS, HCLS1, THPO CTBP2 3440/4885ALDH1A1 19/4885MAPK8 2731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.